Names | |
---|---|
IUPAC name
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline -7-sulfonamide
|
|
Identifiers | |
118876-58-7 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL222519 |
ChemSpider | 2521927 |
ECHA InfoCard | 100.149.984 |
4264 | |
KEGG | C13667 |
PubChem | 3272524 |
|
|
|
|
Properties | |
C12H8N4O6S | |
Molar mass | 336.281 |
Appearance | brown/red powder |
Soluble to 100 mM in DMSO | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione) is an AMPA receptor antagonist.
NBQX blocks AMPA receptors in micromolar concentrations (~10–20 µM) and also blocks kainate receptors. In experiments, it is used to counter glutamate excitotoxicity. NBQX was found to have anticonvulsant activity in rodent seizure models.
As the disodium salt, NBQX is soluble in water at high concentrations (at least up to 100 mM).